IFNG and chronic granulomatous disease: Thus, the production of NO in phagocytes compensates for the ROS deficit in CGD patients treated with IFN-γ, increasing the quality of their respiratory burst and even improving other aspects of phagocytic function such as the clearance of apoptotic bodies.